Literature DB >> 2560110

Persistent parvovirus B19 infections in humans.

N Frickhofen1, N S Young.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2560110     DOI： 10.1016/0882-4010(89)90035-1

Source DB:  PubMed          Journal:  Microb Pathog        ISSN： 0882-4010            Impact factor:   3.738


× No keyword cloud information.
  16 in total

1.  Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.

Authors:  T Saikawa; S Anderson; M Momoeda; S Kajigaya; N S Young
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

2.  Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops.

Authors:  M Zerbini; M Musiani; G Gentilomi; S Venturoli; G Gallinella; R Morandi
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient.

Authors:  P Cassinotti; D Schultze; P Schlageter; S Chevili; G Siegl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

Review 4.  Parvovirus B19 infection and bone marrow transplantation.

Authors:  N Frickhofen; R Arnold; B Hertenstein; M Wiesneth; N S Young
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

5.  Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.

Authors:  S Kajigaya; H Fujii; A Field; S Anderson; S Rosenfeld; L J Anderson; T Shimada; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 6.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

7.  Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests.

Authors:  Kati Hokynar; Päivi Norja; Harri Laitinen; Pekka Palomäki; Antoine Garbarg-Chenon; Annamari Ranki; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

8.  Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis.

Authors:  J G Saal; M Steidle; H Einsele; C A Müller; P Fritz; J Zacher
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

9.  Persistence of parvovirus B19 in synovial fluid and bone marrow.

Authors:  S Nikkari; A Roivainen; P Hannonen; T Möttönen; R Luukkainen; T Yli-Jama; P Toivanen
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

10.  Lymphoproliferative responses after infection with human parvovirus B19.

Authors:  A von Poblotzki; C Gerdes; U Reischl; H Wolf; S Modrow
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.